Treatment of Hematological Malignancies With Nonmyeloablative, HLA-haploidentical Bone Marrow Transplantation and High Dose, Post-Transplantation Cyclophosphamide
Best Practice and Research in Clinical Haematology - United Kingdom
doi 10.1016/j.beha.2011.05.001
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2011
Authors
Publisher
Elsevier BV